These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma. Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324 [TBL] [Abstract][Full Text] [Related]
5. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate. Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703 [TBL] [Abstract][Full Text] [Related]
6. A case of primary intraocular lymphoma treated by intravitreal methotrexate. Kim E; Kim C; Lee J; Cho Y Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection. Ma WL; Hou HA; Hsu YJ; Chen YK; Tang JL; Tsay W; Yeh PT; Yang CM; Lin CP; Tien HF Ann Hematol; 2016 Mar; 95(4):593-601. PubMed ID: 26732884 [TBL] [Abstract][Full Text] [Related]
8. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection]. Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085 [TBL] [Abstract][Full Text] [Related]
9. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma. Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997 [TBL] [Abstract][Full Text] [Related]
10. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721 [TBL] [Abstract][Full Text] [Related]
16. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients. Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978 [TBL] [Abstract][Full Text] [Related]
17. [Malignant lymphoma of the central nervous system and eye]. Tropinskaia OF; Serova NK; Aronov MS; Kobiakov GL Vestn Oftalmol; 2008; 124(1):14-9. PubMed ID: 18318202 [TBL] [Abstract][Full Text] [Related]
18. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate. Reddy R; Kim SJ Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799 [TBL] [Abstract][Full Text] [Related]
19. Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement. Nakauchi Y; Takase H; Sugita S; Mochizuki M; Shibata S; Ishiwata Y; Shibuya Y; Yasuhara M; Miura O; Arai A Int J Hematol; 2010 Jul; 92(1):179-85. PubMed ID: 20464643 [TBL] [Abstract][Full Text] [Related]
20. Intraocular lymphoma: update on diagnosis and management. Chan CC; Wallace DJ Cancer Control; 2004; 11(5):285-95. PubMed ID: 15377987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]